154 related articles for article (PubMed ID: 16804398)
1. Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes.
Glas J; Török HP; Tonenchi L; Müller-Myhsok B; Mussack T; Wetzke M; Klein W; Epplen JT; Griga T; Schiemann U; Lohse P; Seiderer J; Schnitzler F; Brand S; Ochsenkühn T; Folwaczny M; Folwaczny C
Inflamm Bowel Dis; 2006 Jul; 12(7):606-11. PubMed ID: 16804398
[TBL] [Abstract][Full Text] [Related]
2. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.
Zou YF; Wang F; Feng XL; Tao JH; Zhu JM; Pan FM; Su H
Tissue Antigens; 2011 Jan; 77(1):9-17. PubMed ID: 21155719
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
[TBL] [Abstract][Full Text] [Related]
4. Functional polymorphism of the NFKB1 gene promoter is not relevant in predisposition to celiac disease.
Rueda B; Núñez C; López-Nevot MA; Paz Ruiz M; Urcelay E; De la Concha EG; Martín J
Scand J Gastroenterol; 2006 Apr; 41(4):420-3. PubMed ID: 16635909
[TBL] [Abstract][Full Text] [Related]
5. Risk association between the NF-κB1 -94ins/delATTG promoter polymorphism and inflammatory bowel diseases: a meta-analysis.
Liang M; Xu X; Gong Y; Tang Y; Lin L
Dig Dis Sci; 2012 Sep; 57(9):2304-9. PubMed ID: 22828805
[TBL] [Abstract][Full Text] [Related]
6. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
[TBL] [Abstract][Full Text] [Related]
7. The 3'UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients.
Szamosi T; Lakatos PL; ; Szilvasi A; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szabo O; Satori A; Tulassay Z; Miheller P; Horvath HC; Papp J; Tordai A; Andrikovics H
Dig Dis Sci; 2009 Feb; 54(2):351-9. PubMed ID: 18716880
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 (+49A/G) and NOD2/CARD15 (N852S) polymorphisms with inflammatory bowel disease in Turkish patients.
Budak Diler S; Yaraş S
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):97-101. PubMed ID: 30213296
[TBL] [Abstract][Full Text] [Related]
9. A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population.
Oliver J; Gómez-García M; Paco L; López-Nevot MA; Piñero A; Correro F; Martín L; Brieva JA; Nieto A; Martín J
Inflamm Bowel Dis; 2005 Jun; 11(6):576-9. PubMed ID: 15905705
[TBL] [Abstract][Full Text] [Related]
10. Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis.
Zou YF; Yuan FL; Feng XL; Tao JH; Ding N; Pan FM; Wang F
Cancer Invest; 2011 Jan; 29(1):78-85. PubMed ID: 21166501
[TBL] [Abstract][Full Text] [Related]
11. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.
Karban AS; Okazaki T; Panhuysen CI; Gallegos T; Potter JJ; Bailey-Wilson JE; Silverberg MS; Duerr RH; Cho JH; Gregersen PK; Wu Y; Achkar JP; Dassopoulos T; Mezey E; Bayless TM; Nouvet FJ; Brant SR
Hum Mol Genet; 2004 Jan; 13(1):35-45. PubMed ID: 14613970
[TBL] [Abstract][Full Text] [Related]
12. High-resolution melting curve analysis for high-throughput genotyping of NOD2/CARD15 mutations and distribution of these mutations in Slovenian inflammatory bowel diseases patients.
Mitrovič M; Potočnik U
Dis Markers; 2011; 30(5):265-74. PubMed ID: 21734346
[TBL] [Abstract][Full Text] [Related]
13. Interaction between obesity and the NFKB1 - 94ins/delATTG promoter polymorphism in relation to incident acute coronary syndrome: a follow up study in three independent cohorts.
Stegger JG; Schmidt EB; Berentzen TL; Tjønneland A; Vogel U; Rimm E; Sørensen TI; Overvad K; Jensen MK
PLoS One; 2013; 8(5):e63004. PubMed ID: 23671649
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus.
Orozco G; Sánchez E; Collado MD; López-Nevot MA; Paco L; García A; Jiménez-Alonso J; Martín J
Tissue Antigens; 2005 Feb; 65(2):183-6. PubMed ID: 15713218
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population.
Marrakchi R; Moussa A; Ouerhani S; Bougatef K; Bouhaha R; Messai Y; Rouissi K; Khadimallah I; Khodjet-el-Khil H; Najar T; Benammar-Elgaaeid A
Inflamm Res; 2009 Mar; 58(3):155-60. PubMed ID: 19184348
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
[TBL] [Abstract][Full Text] [Related]
17. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
[TBL] [Abstract][Full Text] [Related]
18. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306
[TBL] [Abstract][Full Text] [Related]
19. Hydrocortisone fails to abolish NF-κB1 protein nuclear translocation in deletion allele carriers of the NFKB1 promoter polymorphism (-94ins/delATTG) and is associated with increased 30-day mortality in septic shock.
Schäfer ST; Gessner S; Scherag A; Rump K; Frey UH; Siffert W; Westendorf AM; Steinmann J; Peters J; Adamzik M
PLoS One; 2014; 9(8):e104953. PubMed ID: 25133403
[TBL] [Abstract][Full Text] [Related]
20. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
